Europe’s Pharma, Car Giants Most at Risk From Trump Tariffs
- Drugmakers’ growing reliance on US poses profitability risk
- Tariffs would hurt earnings at BMW, Mercedes, Sandvik, Diageo
This article is for subscribers only.
Supply Lines is a daily newsletter that tracks global trade. Sign up here.
European earnings face significant headwinds should US President Donald Trump’s tariff threats materialize, with the region’s key growth sectors the most exposed.